JP Morgan Private Wealth Advisors’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$1.56M Buy
+6,463
New +$1.65M ﹤0.01% 825
2023
Q2
Sell
-5,643
Closed -$1.06M 1733
2023
Q1
$1.06M Sell
5,643
-222
-4% -$45.9K ﹤0.01% 1137
2022
Q4
$1.25M Sell
5,865
-645
-10% -$129K ﹤0.01% 1040
2022
Q3
$1.02M Buy
6,510
+1,632
+33% +$260K ﹤0.01% 1121
2022
Q2
$730K Sell
4,878
-223
-4% -$32.3K ﹤0.01% 1293
2022
Q1
$835K Sell
5,101
-2,273
-31% -$375K ﹤0.01% 1300
2021
Q4
$1.6M Buy
7,374
+1,782
+32% +$373K ﹤0.01% 1007
2021
Q3
$1.06M Buy
5,592
+146
+3% +$26.6K ﹤0.01% 1186
2021
Q2
$962K Buy
5,446
+514
+10% +$88.7K ﹤0.01% 1218
2021
Q1
$809K Sell
4,932
-23
-0.5% -$3.52K ﹤0.01% 1134
2020
Q4
$690K Buy
+4,955
New +$625K ﹤0.01% 1150

Other funds holding MEDP

JP Morgan Private Wealth Advisors's MEDP Position: Q3 2023 in Review

JP Morgan Private Wealth Advisors opened a new position in Medpace (MEDP) in Q3 2023: 6,463 shares worth $1.56M. The stake represents ﹤0.01% of the portfolio and ranks #825 among its holdings. This is a return to the name: JP Morgan Private Wealth Advisors previously reported a position in MEDP as recently as Q1 2023.

JP Morgan Private Wealth Advisors first reported a position in MEDP in Q4 2020 and has held it in 11 quarters since. The position peaked at $1.6M in Q4 2021. 488 funds tracked by Wall St. Rank hold MEDP as of Q3 2023.

  • JP Morgan Private Wealth Advisors held 6,463 shares of Medpace worth $1.56M as of Q3 2023.
  • Medpace was a new JP Morgan Private Wealth Advisors position in Q3 2023.
  • Medpace made up ﹤0.01% of JP Morgan Private Wealth Advisors's portfolio in Q3 2023, its #825 holding.
  • JP Morgan Private Wealth Advisors first reported a position in Medpace in Q4 2020 and has held it in 11 quarters since.
  • JP Morgan Private Wealth Advisors's Medpace position peaked at $1.6M in Q4 2021.
  • 488 funds tracked by Wall St. Rank held Medpace as of Q3 2023.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.